Literature DB >> 19451295

In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes.

Eric Dannaoui1, Patrick Schwarz, Olivier Lortholary.   

Abstract

The in vitro interaction of antifungals with immunosuppressive drugs was evaluated against zygomycetes. The combination of amphotericin B with cyclosporine, rapamycin, or tacrolimus was synergistic for 90%, 70%, and 30% of the isolates, respectively. For posaconazole, itraconazole, and ravuconazole, synergy was more frequently observed with cyclosporine than with rapamycin or tacrolimus and antagonistic interactions were rarely noted. In summary, calcineurin inhibitors and rapamycin can be synergistic in vitro with amphotericin B and azoles against zygomycetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19451295      PMCID: PMC2715618          DOI: 10.1128/AAC.00184-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

1.  In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents.

Authors:  Eric Dannaoui; Javier Afeltra; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

2.  Calcineurin is essential for survival during membrane stress in Candida albicans.

Authors:  M Cristina Cruz; Alan L Goldstein; Jill R Blankenship; Maurizio Del Poeta; Dana Davis; Maria E Cardenas; John R Perfect; John H McCusker; Joseph Heitman
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

3.  Combination antifungal therapy in treatment of murine pulmonary mucormycosis: roles of quinolones and azoles.

Authors:  A M Sugar; X P Liu
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

4.  Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans.

Authors:  O Marchetti; P Moreillon; M P Glauser; J Bille; D Sanglard
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

5.  Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.

Authors:  Ashraf S Ibrahim; Joel C Bowman; Valentina Avanessian; Keturah Brown; Brad Spellberg; John E Edwards; Cameron M Douglas
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

6.  Immunosuppressive and nonimmunosuppressive cyclosporine analogs are toxic to the opportunistic fungal pathogen Cryptococcus neoformans via cyclophilin-dependent inhibition of calcineurin.

Authors:  M C Cruz; M Del Poeta; P Wang; R Wenger; G Zenke; V F Quesniaux; N R Movva; J R Perfect; M E Cardenas; J Heitman
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

7.  Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans.

Authors:  O Marchetti; J M Entenza; D Sanglard; J Bille; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

8.  Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei.

Authors:  Chiatogu Onyewu; Jill R Blankenship; Maurizio Del Poeta; Joseph Heitman
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

9.  Rapamycin and less immunosuppressive analogs are toxic to Candida albicans and Cryptococcus neoformans via FKBP12-dependent inhibition of TOR.

Authors:  M C Cruz; A L Goldstein; J Blankenship; M Del Poeta; J R Perfect; J H McCusker; Y L Bennani; M E Cardenas; J Heitman
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

10.  Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species.

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis; Nir Osherov; Nathaniel D Albert; Gregory S May
Journal:  J Antimicrob Chemother       Date:  2003-02       Impact factor: 5.790

View more
  21 in total

1.  In vitro combination of anidulafungin and voriconazole against intrinsically azole-susceptible and -resistant Aspergillus spp.

Authors:  Virginie Planche; Sebastien Ducroz; Alexandre Alanio; Marie-Elisabeth Bougnoux; Olivier Lortholary; Eric Dannaoui
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

2.  Rapamycin exerts antifungal activity in vitro and in vivo against Mucor circinelloides via FKBP12-dependent inhibition of Tor.

Authors:  Robert J Bastidas; Cecelia A Shertz; Soo Chan Lee; Joseph Heitman; Maria E Cardenas
Journal:  Eukaryot Cell       Date:  2011-12-30

Review 3.  Calcineurin in fungal virulence and drug resistance: Prospects for harnessing targeted inhibition of calcineurin for an antifungal therapeutic approach.

Authors:  Praveen R Juvvadi; Soo Chan Lee; Joseph Heitman; William J Steinbach
Journal:  Virulence       Date:  2016-06-20       Impact factor: 5.882

Review 4.  Human Fungal Pathogens of Mucorales and Entomophthorales.

Authors:  Leonel Mendoza; Raquel Vilela; Kerstin Voelz; Ashraf S Ibrahim; Kerstin Voigt; Soo Chan Lee
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-06       Impact factor: 6.915

5.  Calcineurin orchestrates dimorphic transitions, antifungal drug responses and host-pathogen interactions of the pathogenic mucoralean fungus Mucor circinelloides.

Authors:  Soo Chan Lee; Alicia Li; Silvia Calo; Makoto Inoue; Nam K Tonthat; Judith M Bain; Johanna Louw; Mari L Shinohara; Lars P Erwig; Maria A Schumacher; Dennis C Ko; Joseph Heitman
Journal:  Mol Microbiol       Date:  2015-06-17       Impact factor: 3.501

6.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

7.  In vitro interactions of calcineurin inhibitors with conventional antifungal agents against the yeast form of Penicillium marneffei.

Authors:  Dongdong Mo; Xin Li; Lili Wei; Chenghang Sun; Hao Liang; Cunwei Cao
Journal:  Mycopathologia       Date:  2014-07-23       Impact factor: 2.574

8.  Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans.

Authors:  Ying-Lien Chen; Virginia N Lehman; Anna F Averette; John R Perfect; Joseph Heitman
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

9.  In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species.

Authors:  Lujuan Gao; Xiaozhen Ding; Zhun Liu; Qingzhi Wu; Tongxiang Zeng; Yi Sun
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.938

10.  Calcofluor white combination antifungal treatments for Trichophyton rubrum and Candida albicans.

Authors:  Joanne M Kingsbury; Joseph Heitman; Sheldon R Pinnell
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.